½ÃÀ庸°í¼­
»óǰÄÚµå
1698270

°í°­µµ Áý¼Ó ÃÊÀ½ÆÄ(HIFU) ½ÃÀå : ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)

High Intensity Focused Ultrasound (HIFU) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 111 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °í°­µµ Áý¼Ó ÃÊÀ½ÆÄ ½ÃÀåÀº 2024³â 6¾ï 8,400¸¸ ´Þ·¯¿¡ À̸£·¶À¸¸ç, 2025-2034³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 10.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

HIFU ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â ħ½ÀÀû ¼ö¼úÀ» ÇÊ¿ä·Î ÇÏÁö ¾Ê°í ´Ù¾çÇÑ º´¸®¸¦ Ä¡·áÇÒ ¼ö ÀÖ´Â È¿´ÉÀ» ÀνÄÇÏ´Â ÇコÄɾî Á¦°ø¾÷ü¿Í ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±Þ¼ÓÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºñħ½ÀÀû Ä¡·á¹ýÀ¸·Î¼­ HIFU´Â Á¾¾çÀ̳ª º»Å¼º ÁøÀüÀ» Æ÷ÇÔÇÑ ¸î¸î ¸¸¼º Áúȯ Ä¡·á¿¡ FDAÀÇ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ÀÌ ±â¼úÀº Áý¼Ó ÃÊÀ½ÆÄ ¿¡³ÊÁö¸¦ ÀÌ¿ëÇÏ¿© ȯºÎ Á¶Á÷À» Á¤È®ÇÏ°Ô Àú°ÝÇϰí ÁÖÀ§¿¡ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ±âÁ¸ ¿Ü°úÀû óġ¿Í ´Þ¸® HIFU´Â ȸº¹ÀÌ ºü¸£°í ÅëÁõÀÌ ÀûÀ¸¸ç Ä¡·á ÈÄ ÇÕº´ÁõÀÌ Àû¾î ȯÀÚ¿Í ÇコÄɾî Àü¹®°¡ ¸ðµÎ ¼±È£Çϰí ÀÖ½À´Ï´Ù.

High Intensity Focused Ultrasound(HIFU) ¸¶ÄÏ-IMG1

À̹Ì¡ ±â¼ú ¹× ½Ç½Ã°£ ¸ð´ÏÅ͸µÀÇ Áøº¸´Â HIFU Ä¡·áÀÇ È¿´É°ú ¾ÈÀü¼ºÀ» ´õ¿í ³ô¿© ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ºñħ½ÀÀûÀÎ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿Í ¾Ï, ÀڱñÙÁ¾, ½Å°æÀå¾Ö µî Áúº´ÀÇ À¯º´·ü »ó½ÂÀÌ °è¼Ó ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¿Ü·¡Ä¡·á ¹× Àúħ½À Ä¡·á·ÎÀÇ ½ÃÇÁÆ®°¡ ÀÇ·á¾÷°è¸¦ À籸¼ºÇϰí ÀÖÀ¸¸ç, HIFU¸¦ Çö´ëÀÇ·á °ÔÀÓ Ã¼ÀÎÀú·Î ´õ ÀÚ¸®¸Å±èÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ºñ¿ë ´ëºñ È¿°ú°¡ ³ô°í, ¸®½ºÅ©°¡ ³·Àº ´ëü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ´Â °¡¿îµ¥, ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ·Î º¸´Ù ¼¼·ÃµÈ HIFU ÀåÄ¡ÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´ÀÚ´Â ÀÇ·á±â°ü°ú Àû±ØÀûÀ¸·Î Çù·ÂÇÏ¿© Á¦Ç° Çõ½ÅÀ» °¡¼ÓÈ­ÇÏ°í ¼¼°èÀÇ ¹ßÀÚÃ븦 È®´ëÇÔÀ¸·Î½á ¼±Áø±¹°ú ½ÅÈï °æÁ¦±¹ ¸ðµÎ¿¡¼­ HIFU ±â¼ú¿¡ ´ëÇÑ Æø³ÐÀº Á¢±ÙÀ» È®º¸Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 6¾ï 8,400¸¸ ´Þ·¯
¿¹Ãø ±Ý¾× 18¾ï 1,000¸¸ ´Þ·¯
CAGR 10.4%

½ÃÀåÀº ¿ëµµº°·Î ±¸ºÐµÇ¸ç, ÁÖ¿ä Ä¡·á ºÐ¾ß´Â ÇǺΰú, ÀڱñÙÁ¾, Àü¸³¼±¾Ï, À¯¹æ¾Ï, ³ì³»Àå, ¿äÅë, º»Å¼º ÁøÀü µîÀÔ´Ï´Ù. 2024³â¿¡´Â ÇǺΰú°¡ ÁÖ¿ä ºÎ¹®À¸·Î ºÎ»óÇÏ¿´À¸¸ç, ºñħ½ÀÀûÀÎ ¹Ì¿ë ½Ã¼úÀÇ Àα⠻ó½ÂÀ¸·Î Å« ¼öÀÍÀ» ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÆäÀ̽º ¸®ÇÁÆ®, ÁÖ¸§ °¨¼Ò, ÇǺΠ±äÃà µîÀÇ Ä¡·á´Â HIFUÀÇ Äݶó°Õ »ý»êÀ» ÀÚ±ØÇϰí ÇǺÎÀÇ Åº·Â¼ºÀ» ³ôÀÌ´Â ´É·Â¿¡ ÀÇÇØ ±âÁ¸ÀÇ ¹Ì¿ë Ä¡·á¸¦ ´ëüÇÏ´Â °ÍÀ¸·Î ¿ä±¸µÇ°í Àֱ⠶§¹®¿¡ ä¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °¡µ¿ ÁßÁö ½Ã°£ÀÌ ¾ø°í Àå±â°£ È¿°ú°¡ Áö¼ÓµÇ´Â HIFU´Â ¹Ì¿ë ¹× °Ç°­ ºÐ¾ß¿¡¼­ °è¼Ó ÁöÁö¸¦ ¸ðÀ¸°í ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î º´¿øÀº 2024³â ½ÃÀå Á¡À¯À² 42.8%¸¦ Â÷ÁöÇßÀ¸¸ç, HIFU ·£µå½ºÄÉÀÌÇÁ¸¦ Áö¹èÇß½À´Ï´Ù. Á¾ÇÕ ÀÇ·áÀÇ ÁÖ¿ä °ø±ÞÀڷμ­ º´¿øÀº HIFU¸¦ ±¤¹üÀ§ÇÑ Áõ»óÀÇ Ä¡·á ÇÁ·ÎÅäÄÝ¿¡ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. FDA ¹× CE¿Í °°Àº ±â°üÀÇ ±ÔÁ¦ ½ÂÀÎÀÌ º´¿ø ä¿ëÀ» °­È­Çϰí ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ ÀÌ ºÐ¾ß¸¦ °è¼Ó °­È­Çϰí ÀÖ½À´Ï´Ù. HIFU°¡ ¼Ò¾Æ¿Í ¼ºÀÎÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ È¯ÀÚÃþ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â °ÍÀÌ º´¿ø¿¡¼­ÀÇ »ç¿ëÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ °í°­µµ Áý¼Ó ÃÊÀ½ÆÄ(HIFU) ½ÃÀåÀº 2023³â¿¡ 2¾ï 2,390¸¸ ´Þ·¯¸¦ âÃâÇÏ¿´À¸¸ç, 2034³â¿¡´Â 6¾ï 450¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ³ª¶óÀÇ ¼±Áø ÇコÄÉ¾î ½Ã½ºÅÛÀº Àü¸³¼± ¾ÏÀÇ ³ôÀº ¹ß»ý·ü°ú ÇÔ²² HIFUÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °­·ÂÇÑ ±ÔÁ¦ ƲÀÇ Á¸Àç, ÇコÄɾî Çõ½Å¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ºñħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ Áøº¸°¡ HIFUÀÇ È¿À²¼º°ú Á¢±Ù¼ºÀ» ³ôÀ̰í Àֱ⠶§¹®¿¡ ¹Ì±¹Àº ¼¼°èÀÇ HIFU ·£µå½ºÄÉÀÌÇÁ¿¡¼­ ÁÖ¿ä ±â¾÷À¸·Î °è¼ÓµÉ ż¼ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º Áúȯ Áõ°¡
      • ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ ¹× »óȯ Á¤Ã¥ Áõ°¡
      • ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ±âÈ£ Áõ°¡
      • ¾Ï ÀÌ¿ÜÀÇ Áúȯ¿¡ ´ëÇÑ ¿ëµµ È®´ë
    • ¾÷°èÀÇ ÀáÀçÀû À§Çè ¹× °úÁ¦
      • Àåºñ ¹× ÀýÂ÷ÀÇ ³ôÀº ºñ¿ë
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • °¸ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­¹®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ÀڱñÙÁ¾
  • Àü¸³¼±¾Ï
  • º»Å¼º ÁøÀü
  • ÇǺΰúÇÐ
  • À¯¹æ¾Ï
  • ³ì³»Àå
  • ¿äÅë
  • ±âŸ ¿ëµµ

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • À̹Ì¡ ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾ ¿ëµµ

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦8Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ALPINION MEDICAL SYSTEMS
  • Arrayus Technologies
  • Chongqing Haifu Medical Technology
  • Focal One
  • FUSMobile
  • Insightec
  • Lynton Lasers
  • Profound Medical
  • Sonablate
  • Theraclion
  • ULTRAISER
  • Verasonics
AJY 25.04.25

The Global High Intensity Focused Ultrasound Market reached USD 684 million in 2024 and is projected to grow at a CAGR of 10.4% between 2025 and 2034. The demand for HIFU technology is rising rapidly as more healthcare providers and patients recognize its effectiveness in treating various medical conditions without the need for invasive surgery. As a non-invasive therapy, HIFU has gained FDA approval for treating several chronic conditions, including tumors and essential tremors. The technology utilizes focused ultrasound energy to target affected tissues with precision, minimizing damage to surrounding areas. Unlike traditional surgical procedures, HIFU offers faster recovery times, reduced pain, and fewer post-treatment complications, making it a preferred choice for patients and healthcare professionals alike.

High Intensity Focused Ultrasound (HIFU) Market - IMG1

Advancements in imaging technology and real-time monitoring have further enhanced the efficacy and safety of HIFU treatments, driving its adoption across diverse medical fields. Increasing awareness of non-invasive therapeutic solutions and the rising prevalence of conditions such as cancer, fibroids, and neurological disorders continue to fuel market expansion. Additionally, the shift toward outpatient care and minimally invasive treatments is reshaping the healthcare industry, further positioning HIFU as a game-changer in modern medicine. As demand for cost-effective, low-risk treatment alternatives surges, investments in research and development are leading to the introduction of more sophisticated HIFU devices. Market players are actively collaborating with healthcare institutions to accelerate product innovation and expand their global footprint, ensuring widespread accessibility of HIFU technology in both developed and emerging economies.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$684 Million
Forecast Value$1.81 Billion
CAGR10.4%

The market is segmented by application, with key treatment areas including dermatology, uterine fibroids, prostate cancer, breast cancer, glaucoma, back pain, and essential tremors. In 2024, dermatology emerged as the leading segment, generating substantial revenue due to the rising popularity of non-invasive aesthetic procedures. Treatments such as facelifts, wrinkle reduction, and skin tightening have witnessed increased adoption, as HIFU's ability to stimulate collagen production and enhance skin elasticity makes it a sought-after alternative to traditional cosmetic procedures. With no downtime and long-lasting results, HIFU continues to gain traction in the beauty and wellness sector, further propelling market growth.

By end-user, hospitals accounted for a 42.8% market share in 2024, dominating the HIFU landscape. As key providers of comprehensive medical care, hospitals are integrating HIFU into treatment protocols for a wide range of conditions. Regulatory approvals from bodies like the FDA and CE have reinforced hospital adoption while increasing investments in healthcare infrastructure continue to strengthen this segment. The ability of HIFU to cater to diverse patient demographics, including children and adults, is further driving its use in hospital settings.

The U.S. High Intensity Focused Ultrasound (HIFU) Market generated USD 223.9 million in 2023 and is expected to reach USD 604.5 million by 2034. The country's advanced healthcare system, coupled with a high incidence of prostate cancer, is driving the widespread adoption of HIFU. The presence of a strong regulatory framework, increasing investment in healthcare innovation, and growing awareness of non-invasive treatment options are contributing to market expansion. As technological advancements continue to enhance the effectiveness and accessibility of HIFU, the U.S. is poised to remain a key player in the global HIFU landscape.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases
      • 3.2.1.2 Increasing regulatory approvals and reimbursement policies
      • 3.2.1.3 Increasing preference for non-invasive therapies
      • 3.2.1.4 Expanding applications in non-cancer diseases
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of equipment and procedures
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Uterine fibroids
  • 5.3 Prostate cancer
  • 5.4 Essential tremor
  • 5.5 Dermatology
  • 5.6 Breast cancer
  • 5.7 Glaucoma
  • 5.8 Backpain
  • 5.9 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Imaging centers
  • 6.4 Other End Use

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 ALPINION MEDICAL SYSTEMS
  • 8.2 Arrayus Technologies
  • 8.3 Chongqing Haifu Medical Technology
  • 8.4 Focal One
  • 8.5 FUSMobile
  • 8.6 Insightec
  • 8.7 Lynton Lasers
  • 8.8 Profound Medical
  • 8.9 Sonablate
  • 8.10 Theraclion
  • 8.11 ULTRAISER
  • 8.12 Verasonics
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦